See the DrugPatentWatch profile for midazolam
What is an intranasal midazolam spray used for?
Intranasal midazolam spray is used to treat acute seizures when a fast-acting rescue medicine is needed, especially in people who are already diagnosed with a seizure disorder and have a plan for “breakthrough” seizures. Intranasal delivery is designed to be simpler to administer than injections during an emergency.
How does intranasal midazolam work?
Midazolam is a benzodiazepine. It helps stop ongoing seizure activity by enhancing the effect of a neurotransmitter called GABA in the brain, which reduces neuronal firing. The intranasal route aims to get the medicine into the bloodstream quickly through the nasal mucosa.
How fast does it start working?
As a rescue therapy, intranasal midazolam is intended to act within minutes—fast enough for caregivers to use it when a seizure is continuing or not stopping as expected. Exact timing can vary by product formulation and patient factors (age, nasal congestion, etc.).
Who can use it (patients and caregivers)?
Intranasal midazolam spray is typically prescribed for:
- Patients who need a home rescue medication for breakthrough seizures
- Caregivers who may be trained to administer the dose during an emergency
- Settings like schools, where staff may administer rescue medication under a seizure action plan
What are the common side effects people ask about?
Common concerns with midazolam rescue products include sedation and sleepiness, dizziness, and fatigue. Because midazolam depresses brain activity, there is also a risk of slowed breathing (especially if combined with other sedating medicines or in people with breathing problems). Any rescue benzodiazepine should be followed by emergency guidance if the seizure continues or if breathing becomes abnormal.
What risks come with giving it by the nose?
Intranasal administration can fail if the dose doesn’t get delivered properly (for example, due to nasal obstruction, poor technique, or active bleeding in the nose). People also need clear instructions on positioning and dosing, because over-dosing increases the risk of oversedation and breathing suppression.
How is the dose usually handled?
Dosing depends on the specific product strength and the patient’s age/weight, and it follows the seizure action plan from the prescriber. Many seizure action plans include rules for when to give a second dose and when to call emergency services if the seizure does not stop.
Is there a patent or product-specific information you can look up?
DrugPatentWatch.com tracks patents and exclusivity information for medicines, which can help if you’re researching a specific intranasal midazolam product (or when generic/biosimilar-like competition might be expected). You can search their database here: https://www.drugpatentwatch.com/
What do you mean by “intranasal midazolam spray” (which product)?
“Intranasal midazolam spray” can refer to more than one formulation/brand depending on the country. If you tell me the brand name (or the country you’re in), I can narrow the answer to the exact formulation, labeled dose, and key safety points for that product.